(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRIMATRIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PRIMATRIX

ST13

US500000085883943

Class

5

Filing

85883943

Registration

4432049

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

04/30/2026

Trademark type

Word

Nice classes

5

Filing date

03/22/2013

Registration date

11/12/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/09/2025

Last transaction

04/30/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

05/31/2005

First use in commerce

05/31/2011

Drawing code

4

Owner type

03

Owner location

PRINCETON, NJ, US

Examiner

REGAN, JOHN B

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

INTEGRA LIFESCIENCES BRAINTREE, INC.
TEI Biosciences Inc.
TEI Biosciences Inc.

Representatives

Eva Tan Integra LifeSciences Corporation

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

biologic collagen graft

Publications

History of USPTO decisions and trademark events.

37 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/29/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/09/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/09/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/09/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/09/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

04/10/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/12/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/09/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/09/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/09/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/09/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/09/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/21/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/21/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/21/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/12/2019

E815

TEAS SECTION 8 & 15 RECEIVED

11/12/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/12/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/28/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/28/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

11/12/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/27/2013

PUBO

PUBLISHED FOR OPPOSITION

08/27/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/07/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/25/2013

ALIE

ASSIGNED TO LIE

07/24/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/02/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

07/02/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/02/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

07/02/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/02/2013

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/02/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/01/2013

DOCK

ASSIGNED TO EXAMINER

07/01/2013

MPMK

NOTICE OF PSEUDO MARK E-MAILED

03/27/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/26/2013

NWAP

NEW APPLICATION ENTERED

03/26/2013

Continuous trademark protection

Get notified about every new filing that threatens PRIMATRIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.